UCP2 and ovarian carcinoma: Indeed, in the ovarian cancer cell line, it has already been shown that increasing mitochondrial ROS by inhibition or knockdown of the ROS‐protective uncoupling protein UCP2 enhances cisplatin‐induced apoptosis [10].